STOCK TITAN

Mirum Pharmaceuticals director plans $1.94M share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Mirum Pharmaceuticals, Inc. (MIRM) officer and director Christopher Peetz reports a planned sale of 20,000 common shares, with an approximate sale date of November 20, 2026, and an aggregate market value of $1,940,100. The shares are listed as acquired from the issuer through a cash-paid stock-option exercise on November 20, 2026; the listed Rule 10b5-1 plan-adoption or instruction date is March 2, 2026. Peetz also lists sales of 20,000 shares for $1,800,000 gross proceeds on November 4, 2026, and 30,000 shares for $2,960,319 on September 1, 2026.

Planned sale 20,000 shares Approximate sale date November 20, 2026
Aggregate market value $1,940,100 Planned sale
Shares outstanding 65,282,044 shares Listed in the Form 144 securities information
Earlier sale 20,000 shares Sale date November 4, 2026
Gross proceeds $1,800,000 Sale date November 4, 2026
Earlier sale 30,000 shares Sale date September 1, 2026
Gross proceeds $2,960,319 Sale date September 1, 2026
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Stock Options Exercise financial
"Nature of Acquisition Transaction: Stock Options Exercise"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MIRM shares does Christopher Peetz plan to sell?

Christopher Peetz plans to sell 20,000 common shares, with an approximate sale date of November 20, 2026. The aggregate market value listed for the sale is $1,940,100.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading